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This study examined whether there were neuroanatomical diﬀerences evident on CT scans of individuals with dementia who
diﬀered on depression history. Neuroanatomical variables consisted of visual ratings of frontal lobe deep white matter, subcortical
white matter, and subcortical gray matter hypodensities in the CT scans of 182 individuals from the Study of Dementia in Swedish
Twins who were diagnosed with dementia and had information on depression history. Compared to individuals with Alzheimer’s
disease and no depression, individuals with Alzheimer’s disease and late-onset depression (ﬁrst depressive episode at age 60 or
over) had a greater number of striatal hypodensities (gray matter hypodensities in the caudate nucleus and lentiform nucleus).
There were no signiﬁcant diﬀerences in frontal lobe deep white matter or subcortical white matter. These ﬁndings suggest that
late-onset depression may be a process that is distinct from the neurodegenerative changes caused by Alzheimer’s disease.
1.Introduction
While some studies have suggested that a history of depres-
sion is a risk factor for dementia later in life (e.g., [1, 2]),
a number of authors have concluded that depression is an
early symptom of dementia [3–6]. Boland [7] proposed
that prodromal depression arises from dementia-related
neuropathology.Severalstudiesofnondementedolderadults
have suggested an association between white matter lesions
and depression, speciﬁcally late-onset depression [8–14]. In
a longitudinal study, white matter changes pre-dated and
independently predicted the onset of depressive symptoms
in older adult participants [15], providing some evidence
that white matter changes are an antecedent to depression.
Furthermore,intheirreview,Schweitzeretal.[16]concluded
that the white matter changes that are common in individu-
als with late-onset depression were associated with cognitive
impairment, and thus, were indicative of a prodrome to
dementia.
A greater amount of total brain white matter lesions has
been associated with more severe depression or a greater
number of depressive symptoms [9, 17, 18]. Other studies
have suggested that white matter lesions in the frontal lobe
are speciﬁcally associated with a higher rate of depressive
symptoms among persons without dementia [8, 19]. A
review of white matter lesions and clinical manifestations
concluded that while periventricular white matter lesions are
often associated with Alzheimer’s disease (AD), lesions in the
subcortical white matter are more often associated with late-
onsetdepression[16].Among39hospitalinpatients overage
60 with severe depression, later age of ﬁrst depressive episode
was associated with a greater severity of subcortical deep
white matter hyperintensities [20]. After a mean followup of
14 months, 27% of the original 39 inpatients had developed
a probable dementia syndrome, which was predicted by a
later age of depression onset and subcortical white matter
hypodensities (WMH) [21].2 Journal of Aging Research
In their review of structural brain abnormalities in aﬀec-
tive disorders, Taylor and Krishnan [22] posit that for late-
onset depression “evidence is strongest for a contributory
eﬀect of [subcortical hyperintensities], particularly as to
hyperintensities of the basal ganglia” (page 61). In fact some
of the earliest studies in this area dating back nearly 20
years noted the greater prevalence and severity of subcortical
hyperintensities among depressed older adults. For example,
Coﬀey et al. [23] found lesions in the subcortical gray
matter nuclei (basal ganglia and thalamus) to be signiﬁcantly
more common in depressed than in nondepressed older
adults (60 years of age and older). Greenwald et al. [24]
sought to further specify the location of the subcortical
lesions associated with late-life depression, comparing the
subcortical gray matter hyperintensities in a group of older
adults receiving treatment for depression to a group of older
adult community controls. In this sample, left-hemisphere
hyperintensities in the putamen, a part of the lenticular
nucleus, which is a component of the striatum, were
signiﬁcantly more common among depressed individuals.
These ﬁndings of an association between frontal
lobe, subcortical deep WMH, and striatal hypodensities
and depression suggest that damage to frontal-subcortical
circutry may be responsible for late-onset depression. Such
damage would be consistent with the frontostriatal hypoth-
esis of depression [25, 26], which suggests that damage
to the frontal lobe and striatum (input nuclei for the
basal ganglia comprised of the caudate nucleus and the
putamen) are associated with depression, though the exact
nature of the association remains unclear. In her review
focusing on subcortical ischemic vascular dementia, Chui
[27]positsthatdeepwhitematterlesionscandisruptfrontal-
subcortical loops and the white matter tracts therein, which
are important for cognition and emotion.
Increasing evidence suggests that the pathenogenesis of
white matter lesions may be largely due to cerebrovascular
disease (CVD). One study [28] indicated that cardiac
insuﬃciency, one of the sequelae of cardiovascular disease,
results in hypoperfusion (decreased blood ﬂow) to sub-
cortical regions of the brain. Frontosubcortical loops and
the associated white matter tracts seem to be especially
vulnerable to hypoperfusion and ischemia [27]. Thus, even
in the absence of a stroke, white matter changes could
occur secondary to CVD-related systemic hypoperfusion
and ischemia. In conjunction with the vascular depression
hypothesis [29], CVD may be considered as a potentially
important antecedent in the relationship between late-life
depression and white matter pathology.
T h ea i mo ft h ep r e s e n ts t u d yw a st oe v a l u a t en e u -
roanatomical alterations on the CT scans of individuals
with dementia based upon a history of late-onset depression
(LOD, ﬁrst episode of depression at age 60 or older) or late-
life depression (LLD, any episode of depression at age 60
or older). We hypothesized that individuals with dementia
and LOD and/or LLD would be more likely than non-
depressedindividualswithdementiatoexhibithypodensities
in the frontal lobe deep white matter and subcortical white
matter (subinsular region and internal capsule), as well as
the subcortical striatal gray matter (caudate nucleus and
lentiform nucleus, which includes the putamen and globus
pallidus) on CT scans. We further hypothesized that these
patterns would be evident among all demented individuals
and in Alzheimer’s disease alone.
2. Methods
2.1. Participants. Study participants were part of the Study
of Dementia in Swedish Twins (HARMONY) [30]. The
HARMONY study population included all twins in the
Swedish Twin Registry [31] who were aged 65 and older and
alive during the telephone-screening phase. Although this
study uses data from Swedish twins, it is not a twin study
per se.
Dementia was ascertained through a two-step procedure
that entailed an initial cognitive screening with a subsequent
diagnostic workup of each suspected case. In brief, the
TELE [32, 33] and the Blessed Dementia Rating Scale
(BDRS) [34] were used to screen for cognitive dysfunction.
Twins who screened positive for suspicion of dementia
(and their twin partners) were evaluated in person by a
physician and nurse. Final diagnoses of dementia were deter-
mined by a multidisciplinary consensus board. Dementia
was diagnosed according to the criteria in the Diagnostic
and Statistical Manual of Mental Disorders IV [35]a n d
diﬀerentially diagnosed for AD versus vascular dementia
using NINCDS/ADRDA [36] and NINDS-AIREN criteria
[37].TheHARMONYstudyusedtwosourcesofinformation
to estimate the age of dementia onset: informant reporting
during an in-depth semistructured interview and medical
records [38].
T h es a m p l ef o rt h ep r e s e n ts t u d y( N = 238) consisted
of all HARMONY twins who (1) were diagnosed as having
dementia,(2)hadahardcopyoftheirCTscan(performedas
part of the clinical phase of dementia assessment) that could
be assessed by the CT raters, and (3) did not meet any of the
exclusion criteria (see Figure 1). Exclusion criteria included
missing information on timing of depressive episodes (N =
4) or ﬁrst depression onset more than six months after the
scan date (N = 2).
Of the 238 CT scans scored by the raters, 56 were
excluded during the rating process. Four scans were excluded
due to the poor quality of the scan, 45 because there was
evidence of major stroke (i.e., middle cerebral artery stroke,
posterior cerebral artery stroke), 2 because of hydrocephalus,
and 5 because of other major brain problems (e.g., evidence
of major brain surgery or traumatic brain injury). Those
with evidence of a minor stroke (i.e., small lacunar infarct)
were not excluded. The ﬁnal sample included white matter
hypodensity and striatal hypodensity ratings for 182 individ-
uals.
2.2. Neuroimaging. Diagnostic neuroimaging utilized CT
scansbecauseatthetimeoftheclinicaldiagnosticassessment
insuﬃcient numbers of participants lived close to MRI
centers. Twins completed CT scans at their most convenient
participating CT center. All CT technicians were given
standardized instructions to perform a CT of the brain withJournal of Aging Research 3
244 CT scans available
4 missing age of
depression onset
2 depression onset after scan
238 CT scans rated
45 MCA/PCA stroke
5 other severe brain
pathology
23 minor stroke
(not excluded)
Data analyzed:
182 rated for WMH
2 hydrocephalus
4 poor quality scan
Figure 1: Study sample.
standard slices and noncontrast enhancement. The slices
were to be four to ﬁve millimeters from the base of the
skull and eight to ten millimeters from the pars petrosa
ossis temporalis. Contrast enhancement was performed if
needed for clinical reasons. The diagnostic protocol allowed
individuals who had a CT within six months prior to the
clinical workup to provide a copy of that scan instead. After
obtaining a clinical read, CT scans were deidentiﬁed and
made available for research purposes.
2.3. Visual Rating of CT Scans. B.M.S. and J.L.G. served as
the CT raters. Raters were blind to clinical diagnosis and
any demographic information, including which scans were
from twin pairs, as well as the age, gender, and zygosity of
the scanned individual. If either rater determined that an
image quality was unacceptable, it was excluded from the
analyses. If there was evidence of a major stroke, such as
middle cerebral artery or posterior cerebral artery stroke, the
CT was not included in the analyses. Individuals with small
lacunar infarcts, however, were not excluded. CT scans that
indicated hydrocephalus or other severe neuropathology,
such as evidence of a brain tumor, major brain surgery, or
traumatic brain injury, were also excluded from the analyses.
2.3.1. Frontal Deep White Matter Hypodensities. Deep white
matter hypodensities in the frontal lobe were rated on a
modiﬁed version of the Age-Related White Matter Changes
(ARWMC)Scale[39],where0=anabsenceofhypodensities,
1 = one focal hypodensity (≥5mm), 2 = more than one focal
hypodensity, 3 = conﬂuent hypodensities, and 4 = conﬂuent
hypodensities with additional discrete focal hypodensities.
Focal hypodensities were deﬁned as discrete hypodensities
greater than ﬁve millimeters in size. Conﬂuent hypodensities
were present when discrete hypodensities could not be sep-
arately deﬁned. Deep white matter hypodensities (DWMH)
were deﬁned as WMH that were located medially from the
sulci. The ratings of frontal DWMH in the right and left
hemisphere were highly correlated (Spearman’s rho = 0.92,
P<0.0001). Therefore, summary scores for frontal DWMH
used the maximum score for the right and left hemispheres.
2.3.2. Subcortical White Matter Hypodensities. The density of
thewhitematterintheinternalcapsuleandsubinsularregion
(comprised of the external capsule, claustrum, and extreme
capsule) was compared to the density of homogenous areas
of white matter in the frontal lobe to determine if there
were relative hypodensities evident in either of these com-
ponents. The location, side (left versus right hemisphere),
and rating of the hypodensities within these regions were
indicated, with hypodensities rated on the modiﬁed version
of the ARWMC Scale. The ratings of subcortical WMH in
the right and left hemisphere were signiﬁcantly correlated
(Spearman’s rho = 0.79, P<0.0001); a summary subcortical
WMH score was created using the maximum score for the
right and left hemispheres.
2.3.3. Basal Ganglia-Thalamic Hypodensities. The raters also
examined each scan for gray matter hypodensities in the
basal ganglia and thalamic regions. The homogeny of the
gray matter in the striatum (caudate nucleus and lentiform
nucleus), substantia nigra, and thalamus were compared to
one another to identify hypodensities. The total number
of hypodensities in the striatum on both right and left
hemispheres was summed.
2.3.4. Interrater Reliability. Each CT scan was scored sep-
arately by both raters. Interrater reliability for bilateral
WMH was substantial (weighted kappa, right WMH = 0.92;
weighted kappa, left WMH = 0.89) and slightly lower though
adequate for bilateral basal ganglia-thalamic hypodensity
ratings (weighted kappa, right = 0.73; weighted kappa, left
= 0.62). In cases of disagreement, the scans were rerated
conjointly, and the consensus rating was used for analysis.
2.4.Depression. Historyofdepression,comorbiddepression,
and estimated age of depressive episodes were determined
using information from four sources: (1) the national
computerized Inpatient Discharge Registry (IDR), (2) the
nationalregistryofinpatientpsychiatrichospitalservices,(3)
medical history provided by an informant, and (4) medical
records.
The Swedish Twin Registry is linked to the national
computerized Inpatient Discharge Registry that records all
inpatient hospital discharges in Sweden. Discharge diagnoses
useInternationalClassiﬁcationofDisease(ICD)codes.Ifthe
dischargedatewaspriorto1969,theICD-7codeddepression
diagnoses as 302 (involutional melancholia), 314 (depressive
neurosis), and 790.2 (other recurrent depressive disorder). If4 Journal of Aging Research
the discharge date was 1969–1986, the ICD-8 coded depres-
sion diagnoses as 296.0 (involutional melancholia), 298
(reactive depressive psychosis), 300.4 (depressive neurosis),
and 790.2 (other recurrent depressive disorder). If the date
of discharge was 1987–1996, the ICD-9 coded depression
diagnoses similar to the ICD-8, with 296.2 (depressive
psychosis), 296.3 (recurrent depressive psychosis), 296.82
(atypical depression), 300.4 (dysthymia), and 311 (depres-
sion, NOS). From 1997, the ICD-10 depression diagnoses
included F32 (depressive episode), F33 (recurrent depressive
disorder), and F34.1 (dysthymia). There were 11 participants
with discharge diagnoses of depression in the Inpatient
Discharge Registry.
The Swedish Twin Registry has also been linked to a
national registry of inpatient psychiatric hospital services
thatwasmaintainedbetween1967and1983.Foreachperson
entered in this registry, there is a record of the discharge
diagnosis and the date of hospitalization. All diagnoses are
given in terms of an ICD-8 diagnosis (see above). There
were two participants with diagnoses of depression in the
inpatient psychiatric hospital services registry, both of whom
also had a diagnosis of depression in the Inpatient Discharge
Registry.
Thus, a total of 11 participants in this study had at
least one depression-related discharge diagnosis in the IDR
between the years of 1964 and 2004, a span of 40 years,
or between 1967 and 1984 in the inpatient psychiatric
hospital services registry. The most common depression-
related discharge diagnosis was depression not otherwise
speciﬁed, followed by dysthymia, recurrent depressive dis-
orders, and depressive episodes of mild, severe, or other
characteristics. Discharge diagnoses in both the IDR and
the psychiatric hospital discharge registry that were regarded
as not depression-related included bipolar aﬀective disorder
and manic-depressive reaction, manic or unspeciﬁed type,
schizoaﬀective disorder, and unspeciﬁed mood disorders.
Medical history reported by an informant was collected
during the clinical evaluation. The history included whether
the individual had any history of “major depressive disorder”
or “reactive depression,” and if so, the date or dates of onset.
The ﬁrst depressive episode according to the medical history
used the earliest date recorded for the onset of a depressive
disorder and the most recent episode of depression used the
latest date recorded for a depressive episode.
Medical records, ordered during the clinical evaluation
phase, were coded by the assessment team to reﬂect whether
the twin had been diagnosed with depression. Records
typically go back approximately ten years before the clinical
evaluation for dementia. Thus, these records were most
helpful in determining whether late-life depression was
present. Data included the onset and dates of depression.
Use of antidepressant medications was also coded from
the medical records and medical history. A total of 31
individuals were prescribed antidepressant medication, but
did not have any other information indicating that they had
ever received a diagnosis of depression. These individuals
were coded as not having a history of depression, as it is
possible that these medications were prescribed for reasons
other than depression.
The age of the ﬁrst episode of depression was determined
using the age at the earliest reported occurrence of depres-
sion across all sources. Individuals with a ﬁrst episode of
depression at age 60 or older were considered to have late-
onset depression (LOD). Individuals who had prior episodes
of depression including at least one episode of depression
at age 60 or over were considered to have a history of
late-life depression (LLD). In sum, a total of 132 (72.5%)
individuals did not have a history of a depression diagnosis
and 50 (28.5%) individuals had a history of a depression
diagnosis.Oftheseindividuals,36hadLOD,havingtheirﬁrst
depressive episode after age 60, with a mean (SD) age of ﬁrst
depressive episode of 74.2 (7.0) years. Of the 14 individuals
who had their ﬁrst depressive episode before age 60, nine
individuals had an episode of depression occurring after age
60. Thus, 45 of the 182 participants were considered to have
LLD. Those with an early episode of depression that did not
recur in later life (N = 5) were not included in further
analyses.
2.5. Cerebrovascular Disease. Cerebrovascular disease risk
factors, as indicators of CVD risk, were examined as
potentially important covariate. Data on hypertension, dia-
betes, atrial ﬁbrillation, peripheral artery disease, transient
ischemic attack, and coronary artery disease (CAD) indica-
tors were extracted from the participant’s medical records
and coded by the assessment team to reﬂect whether the
individualhadahistoryofanyoftheseriskfactors.Coronary
artery disease was considered present if the individual had a
history of myocardial infarction, angina, or heart failure.
2.6. Other Covariates. Additional covariates included age
at the time of the CT scan, dementia duration (i.e., age
at the time of the scan compared with age of dementia
onset), gender, zygosity, and number of years of education
completed. Because of the cross-sectional study design,
particular attention was paid to the duration of dementia
at the time of the CT scan (calculated by subtracting age of
dementia onset from the age at the CT scan).
2.7. Analyses. Associations between history of LOD (no
depression versus LOD) and all potential demographic and
medical confounders were initially examined to determine
factors to include as covariates in multivariate models. Chi-
square tests were used to examine whether gender, zygosity,
or risk factors for CVD (hypertension, diabetes, atrial ﬁbril-
lation, peripheral artery disease, transient ischemic attack,
and coronary artery disease indicators) diﬀered by history
of LOD. One-way ANOVA was used to determine whether
age at CT scan, age of dementia onset, duration of dementia
at the time of the CT scan, or level of education diﬀered by
presence versus absence of LOD.
Kruskal-Wallis chi-square was used to examine whether
frontal deep white matter or subcortical white matter score
varied by age at CT scan or dementia duration. Fisher’s
Exact Test was used to determine whether frontal deep white
matter or subcortical white matter score diﬀered by gender.
Simple linear regression was used to test whether numberJournal of Aging Research 5
of striatal hypodensities varied by age, gender, or dementia
duration. We took a conservative approach to determining
which potential confounders should be included in the ﬁnal
model, including covariates with an association of P<0.15.
Logistic regression for dichotomous outcomes control-
ling for gender and history of TIA was used to examine
the association between LOD and the presence of any
frontal lobe deep WMH (focal and conﬂuent WMH versus
no WMH), as well as between LOD and the presence of
conﬂuent frontal lobe deep WHM (conﬂuent WMH versus
no WMH and focal WMH only). To analyze the relationship
between LOD and level of subcortical WMH (0 = no WMH,
1 = one WMH, 2 = more than one WMH, 3 = conﬂuent
WMH), ordinal logistic regression was used, controlling
for age at CT scan and zygosity. The association between
numbers of striatal hypodensities and LOD was examined
using one-way ANOVA; there were no demographic or
medical covariates associated with striatal hypodensities. All
of the analyses testing white matter associations with LOD
were reanalyzed using LLD. Finally two sets of analyses were
performed, the ﬁrst using all participants with dementia and
the second using only individuals with Alzheimer’s disease.
Seven complete twin pairs were included in these anal-
yses. To account for the possibility that these seven pairs
had correlated data, we also used generalized estimating
equations (GEE) to examine the association between the
presence of frontal deep WMH and LOD, the amount of
subcortical WMH and LOD, and the number of striatal
hypodensities and LOD for both the total sample and the
Alzheimer’s disease only sample. GEE accounts for the lack
of independence between twin observations.
3. Results
The most frequent type of dementia among these 182 indi-
viduals was Alzheimer’s disease (N = 127, 69.8%), followed
by vascular dementia (N = 29, 15.9%) and dementia not
otherwise speciﬁed (N = 16, 8.8%). An additional ﬁve
participants (2.7%) were diagnosed with dementia of a
mixed type (both Alzheimer’s disease and vascular dementia
pathology) and another ﬁve (2.7%) individuals had other
forms of dementia (e.g., frontotemporal dementia). Average
duration of dementia (from dementia onset to date of CT
scan) was 5.2 years (SD = 4.25, range 0–23 years). The
majority of participants were female (n = 116, 63.7%) and
the average age at CT scan was 80.6 years (SD = 6.7 years,
range 56–96 years). Participants had 7.4 years (SD = 2.4)
of education on average, and 51 participants (28.0%) were
from a monozygotic twin pair. Demographic characteristics
are presented in Table 1 for all dementias and for Alzheimer’s
disease alone.
3.1. Associations between Imaging Data and Sample Demo-
graphic Characteristics. Across all study participants, 39.6%
(N = 72) had at least one hypodensity in the frontal
lobe deep white matter and 51.6% (N = 94) had at least
one subcortical white matter hypodensity. Among the 94
participants with subcortical white matter hypodensities, the
majority (N = 88, 93.6%) had at least one hypodensity in
the subinsular region, only six individuals had hypodensities
solely within the internal capsule, and 30.8% (N = 29) had
hypodensities both in the subinsular region and the internal
capsule.
Age at the time of the scan, duration of dementia, and
education werenot associated with frontaldeep white matter
hypodensities. Male gender was associated with the presence
of frontal deep white matter hypodensities (53.0% of males
versus 34.5% females; P = 0.01); gender was therefore
included as a covariate in the multivariate logistic regression
analysis. Zygosity was not associated with presence of frontal
lobe deep WMH.
AgeatthetimeoftheCTscanwassigniﬁcantlyassociated
with subcortical white matter hypodensities, such that older
individuals had more subcortical WMH (χ2 = 1.59,df =
3,P = 0.03). Individuals who were monozygotic twins were
less likely than nonmonozygotic twins to have subcortical
WMH (37.2% of monozygotic twins; 57.2% of dizygotic
twins; χ2 = 10.43,df = 3,P = 0.02). Gender, education, and
duration of dementia were not associated with subcortical
white matter hypodensities. Thus, age at the time of the
CT scan and zygosity were included as covariates in the
multivariate ordinal logistic regression models.
Across all study participants, 30.8% (N = 56) had at least
one hypodensity in the striatum. A simple linear regression
analysis indicated that age at the time of the scan, education,
and the duration of dementia were not associated with the
number of striatal hypodensities. Gender and zygosity were
also not associated with striatial hypodensities.
3.2. Associations between Imaging Data and Vascular Risk
Factors. Presence of frontal deep WMH, level of subcortical
WMH severity, and total number of striatal hypodensities
didnotsigniﬁcantlyvarybyhistoryofCAD.HistoryofaTIA
waspresentfor14individualsinthenondepressedgroupand
no individuals with a history of depression. Controlling for
gender, individuals with a history of TIA were 3.92 (95% CI
= 1.16, 13.24, P = 0.03) times more likely than individuals
without a history of TIA to have hypodensities in the frontal
lobe deep white matter. Amount of subcortical WMH and
striatal hypodensities did not signiﬁcantly vary by history of
TIA.
3.3. Associations between Imaging Data and Dementia Type.
A logistic regression model controlling for gender indicated
thatindividualswithvasculardementiawere2.67timesmore
likely to have frontal lobe deep WMH than individuals with
other types of dementia (95% CI = 1.24, 5.76, P = 0.012).
Gender also remained signiﬁcant, and men were 1.85 times
more likely to have frontal lobe deep WMH than women
(95% CI = 1.08, 3.61, P = 0.025). Although individuals
with vascular dementia were more likely to have a higher
ranked amount of subcortical WMH, this association was
not statistically signiﬁcant (P = 0.14). Presence of striatal
hypodensities did not diﬀer according to dementia type.
3.4. Depression Status. Individuals with no history of depres-
sion and individuals with LOD did not diﬀer signiﬁcantly6 Journal of Aging Research
Table 1: Sample demographics and covariates for all dementia and alzheimer’s disease only.
N All dementia Alzheimer’s disease
182 127
Age at CT scan (SD) 80.6 (6.7) 80.8 (6.9)
Duration of dementia (SD) 5.2 (4.2) 5.1 (4.2)
Female, n (%) 116 (63.7) 86 (67.7)
Education, years (SD) 7.4 (2.4) 7.5 (2.6)
Monozygotic, n (%) 51 (28.0) 40 (31.5)
Hypertension, n (%) 153 (84.1) 104 (81.9)
Diabetes, n (%) 43 (23.6) 24 (18.9)
Arrhythmia, n (%) 36 (19.8) 25 (19.7)
PAD, n (%) 4 (2.2) 2 (1.6)
CAD, n (%) 59 (32.4) 38 (30.0)
TIA, n (%) 14 (7.7) 6 (4.7)
Any CVD, n (%) 166 (91.2) 113 (89.0)
PAD: peripheral artery disease; CAD: coronary artery disease; TIA: transient ischemic attack; CVD: cerebrovascular disease.
on most demographic variables (Table 2). Similarly, no
diﬀerences were observed between the non-depressed and
the LLD groups. Participants in the LOD group were more
likely to be a member of a monozygotic twin pair compared
to non-depressed participants (P = 0.05). Gender and years
of education did not signiﬁcantly diﬀer by either history of
LOD or history of LLD.
Among all study participants, the mean (SD) duration of
dementiaatthetimeoftheCTscanwas5.2(4.2)years.There
was no signiﬁcant diﬀerence between the no depression and
the LOD group with respect to duration of dementia at the
time of the CT scan. At the time of the CT scan, those with
LOD had an average dementia duration of 4.2 years (SD =
3.5) and individuals with no history of depression had an
average dementia duration of 5.2 years (SD = 4.2).
T h ep r e s e n c eo fC A Da n dT I Ad i ﬀered by depression
group(Table2).Individualsinthenon-depressedgroupwere
more likely to have had a transient ischemic attack than
individuals in the LOD group (P = 0.04). Individuals with
LOD were more likely than non-depressed individuals (RR
= 1.43, 95% CI = 0.92, 22.33, P = 0.13) to have a history
of CAD. CAD was not signiﬁcantly more prevalent, however,
in the LLD group (40.0%) compared to the no depression
group (31.1%; P value for diﬀerence = 0.27).
3.5.WhiteMatterHypodensitiesandLOD/LLD. Amongindi-
viduals with LOD, if there were hypodensities in the frontal
lobedeepwhitematter,theyweregenerallyratedasconﬂuent
(92.9% of deep WMH were rated as conﬂuent). Therefore,
we examined whether LOD was associated with conﬂuent
hypodensities, testing frontal deep WMH (DWMH) as
a dichotomous variable—conﬂuent frontal lobe DWMH
versus nonconﬂuent (no or only focal hypodensities) frontal
lobe DWMH. Controlling for gender, LOD was not signif-
icantly associated with a greater risk of conﬂuent frontal
lobe DWMH for both the total dementia and Alzheimer’s
disease only analyses, although the pattern of the results was
in the hypothesized direction (Table 3). A similar pattern
was observed for LLD, where, after controlling for gender,
the association between LLD and risk of conﬂuent frontal
lobe DWMH was nonsigniﬁcant for both the total dementia
(OR = 1.38, 95% CI = 0.66, 2.88) and Alzheimer’s disease
only (OR = 2.12, 95% CI = 0.86, 5.28). There was no
association between frontal lobe DWMH dichotomized as
presence versus absence of hypodensities and dementia or
AD (Table 4).
After controlling for age at CT scan and zygosity, no
association was observed between subcortical WMH and
LOD. The distribution of subcortical WMH is shown in
Table 5. Results were similar for LLD versus no depression
comparison. A greater age at the time of the CT scan and
a greater amount of subcortical WMH (OR = 1.08 per year
of age, 95% CI = 1.01, 1.12, P = 0.006) were the only
statistically signiﬁcant association in the multivariate model.
3.6. Striatal Hypodensities and LOD/LLD. Number of stri-
atial hypodensities is shown in Table 6. One-way ANOVA
indicated signiﬁcantly more striatal hypodensities for indi-
viduals with late-onset depression compared with non-
depressed individuals when AD was considered alone. The
patterns when comparing LOD to total dementia and when
comparing LLD to non-depressed were similar (0.05 <
P<0.10). GEE was used to account for the possible
correlation between twin pairs. The relationship between a
greater number of striatal hypodensities and LOD remained
signiﬁcant (OR = 2.27, 95% CI = 1.02, 5.05).
3.7. Source of Depression Information. Despite the dem-
onstrated concordance between medical records and
informant-reported depression, we examined in a post hoc
analysis whether the relationships between hypodensities
and depression diﬀered based upon the source of
information about depression. There was no signiﬁcant
diﬀerence in the relationship between frontal DWMH,
subcortical WMH, striatal hypodensities and depression
when informant-reported medical history information was
disregarded. There were also eight individuals missing eitherJournal of Aging Research 7
Table 2: Sample demographics by depression group.
N No Depression LOD P value∗
132 36
Age at CT scan (SD) 81.1 (6.1) 81.0 (7.0) n.s.
Age at dementia onset (SD) 75.9 (6.9) 76.9 (6.7) n.s.
Dementia duration, years (SD) 5.2 (4.2) 4.2 (3.5) n.s.
% Female 63.6 63.9 n.s.
Education, years (SD) 7.5 (2.4) 7.4 (2.8) n.s.
Monozygotic, n (%) 33 (25.0) 15 (41.7) 0.05
Hypertension, n (%) 113 (85.6) 30 (83.3) n.s.
Diabetes, n (%) 32 (24.2) 6 (16.7) n.s.
Arrhythmia, n (%) 25 (18.9) 8 (22.2) n.s.
PAD, n (%) 3 (2.3) 1 (2.8) n.s.
CAD, n (%) 41 (31.1) 16 (44.4) 0.13
TIA, n (%) 14 (10.7) 0 (0.0) 0.04
Associations signiﬁcant at P<0.15 are bolded.
LOD: late-onset depression; PAD: peripheral artery disease; CAD: coronary artery disease; TIA: transient ischemic attack.
∗Group comparisons by ANOVA for continuous variables and by chi-square for categorical variables.
Table 3: Risk of conﬂuent frontal lobe deep white matter hypodensities in late-onset depression compared with No depression for all
dementia and alzheimer’s disease.
No depression Late-onset depression
−Con WMH +Con WMH −Con WMH +Con WMH OR∗
N (%) N (%) N (%) N (%) (95% CI)
All dementia 97 (73.5) 35 (26.5) 23 (63.9) 13 (36.1) 1.58 (0.72, 3.46)
AD only 73 (76.8) 22 (23.2) 16 (64.0) 9 (36.0) 1.83 (0.70, 4.79)
−ConWMH: Conﬂuent frontal deep white matter hypodensities absent; +ConWMH: Conﬂuent frontal deep white matter hypodensities present; OR: Binary
logit odds ratio estimate, controlling for gender; CI: conﬁdence interval; AD: Alzheimer’s disease.
∗Late-onset depression group compared to no depression group.
Table 4: risk of frontal lobe deep white matter hypodensities in late-onset depression compared with no depression for all dementia and
Alzheimer’s disease.
No depression Late-onset depression
−WMH +WMH −WMH +WMH OR
N (%) N (%) N (%) N (%) (95% CI)∗
All dementia 75 (56.8) 57 (43.2) 22 (61.1) 14 (38.9) 0.96 (0.44, 2.08)
AD only 59 (62.1) 36 (37.9) 16 (64.0) 9 (36.0) 0.88 (0.35, 2.25)
−WMH: frontal deep white matter hypodensities absent; +WMH: frontal deep white matter hypodensities present; OR: binary logit odds ratio estimate,
controlling for gender; CI: conﬁdence interval; AD: Alzheimer’s disease.
∗Late-onset depression group compared to no depression group.
Table 5: risk of subcortical white matter hypodensities in late-onset depression compared with no depression for all dementia and
Alzheimer’s disease only.
No depression Late-onset depression
Level of WMH∗ 0 1 2 3 0 1 2 3 OR (95% CI)∗∗
All dementia 62 (47.0) 16 (12.1) 25 (18.9) 29 (22.0) 17 (47.2) 3 (8.33) 9 (25.0) 7 (19.4) 0.97 (0.48, 1.92)
AD only 48 (50.5) 11 (11.6) 18 (18.9) 18 (18.9) 12 (48.0) 2 (8.0) 5 (20.0) 6 (24.0) 1.16 (0.48, 2.58)
OR: ordinal cumulative logit odds ratio estimate, controlling for age at time of CT scan; CI: conﬁdence interval; AD: Alzheimer’s disease.
Level of WMH: 0 = none, 1 = one discrete hypodensity, 2 = more than one discrete hypodensity, 3 = conﬂuent hypodensities.
∗All numbers for Level of WMH given in terms of N (%). ∗∗Late-onset depression group compared to no depression group.8 Journal of Aging Research
Table 6: number of striatal hypodensities in late-onset depression
compared with no depression for all dementia and Alzheimer’s
disease only.
No depression LOD No depression
versus LOD∗
All dementia
N 132 36
Striatum,
mean (SD) 0.48 (0.96) 0.86 (1.53) 0.07
Alzheimer’s
disease only
N 95 25
Striatum,
mean (SD) 0.42 (0.92) 0.96 (1.72) 0.03
LOD: late-onset depression.
∗P value.
an informant report (N = 6) or coded medical records
(N = 2). Dropping these individuals from our analyses did
not aﬀect the outcomes of our analyses.
4. Discussion
The aim of the present study was to investigate the under-
lying neural mechanisms linking depression and dementia,
stemming from the idea that there could be a pathophysi-
ological basis in the brain for the comorbidity of depression
anddementia[1].Accordingtothefronto-striatalhypothesis
of vascular depression, white and gray matter lesions in
the fronto-striatal pathway resulting from cerebrovascular
disease (as well as normal aging) may cause late-onset
depression [25]. In line with the fronto-striatal hypothesis,
we predicted that demented individuals with a LOD or a
history of LLD would have a higher prevalence of WMH
in the frontal lobe deep white matter and subcortical
white matter, as well as a greater amount of gray matter
hypodensities in the striatum, compared to individuals with
dementia and no depression. While similar hypotheses have
been tested among individuals with late-onset and/or late-
life depression, they have rarely been considered among
individualswithbothdementiaandlate-onsetand/orlatelife
depression.
In support of one of the main hypotheses of the study,
individuals speciﬁcally with Alzheimer’s disease and late-
onset depression had a signiﬁcantly greater total amount
of striatal hypodensities compared to individuals with
Alzheimer’s disease and no history of depression. Further
analysis revealed that this association was not explained by
any other medical or demographic covariate and remained
signiﬁcant even after accounting for the possibility that
the twin pairs included in the study sample were not
truly independent observations. According to the bivariate
level analyses, there were no associations between striatal
hypodensitiesandanyofthedemographicormedicalhistory
confounders. Only CAD diﬀered between the LOD and
non-depressed group in the individuals with AD (χ2 =
3.89,df = 1, P = 0.048), with the LOD group more
likely to have CAD than the non-depressed group (48.0%
versus 27.4%, resp.). However, CAD was not associated
with number of total striatal hypodensities. Thus, there
were no other tested covariates that could explain the
association we found between the LOD group and striatal
hypodensities among the AD group. Although there was a
consistent pattern of ﬁndings for striatal hypodensities, the
ﬁnding was statistically signiﬁcant only among those with
Alzheimer’sdiseaseinparticular,whencomparingthosewith
late-onset depression to those with no earlier history of
depression.
Although the direction of some of the associations
was consistent with our hypotheses, the presence (versus
absence) of frontal lobe deep WMH did not diﬀer signiﬁ-
cantly between the non-depressed and LOD or LLD groups,
nor did severity of subcortical white matter hypodensities
diﬀer between the nondepressed and LOD or LLD groups.
Male gender and a history of TIA were the only two
signiﬁcant predictors of presence of frontal lobe deep
WMH. While the prevalence of ischemic neuropathology
on CT in cognitively intact patients with TIAs has been
estimated at approximately 40%, most abnormalities are
diﬀuse throughout the cerebral white matter or basal ganglia
[40]. Therefore, our ﬁnding that hypodensities were speciﬁc
to the frontal lobe deep white matter may be speciﬁc to
individuals with dementia. Severity of subcortical WMH was
only associated with age at CT scan.
4.1. White Matter Hypodensities and LOD/LLD. Our lack
of statistically signiﬁcant ﬁndings with respect to the white
matter components of the fronto-striatal pathway was sur-
prising in light of the solid base of literature supporting an
association with late-onset and late-life depression. Several
diﬀerences between the present study and past studies may
explain this discrepancy. Most of the study populations that
found the association between WMH and LOD and LLD
were comprised of cognitively intact older adults or older
adults with mild cognitive impairment. All of the individuals
in the present study had dementia, with approximately 70%
diagnosed with Alzheimer’s disease. Therefore, this study at
least partially “controls” for the neuropathology related to
dementia. However, it could be that by the time cognitive
and functional impairment has progressed to the point
of dementia, the neurological damage caused by dementia
is widespread enough to subsume the neuropathology of
late-onset depression such that the two neuropathologies
become indistinct. In fact, this may even happen in the
early stages of dementia, as suggested by a study of mildly
demented patients both with and without a subsyndromal
level of depressive symptoms, which failed to ﬁnd any
signiﬁcant relationship between white matter changes and
depressive symptoms [41]. At variance with this, however,
Lavretsky et al. [18] found that higher lacunar volume in
the white matter was associated with neuropsychiatric symp-
toms (including depressed mood, anhedonia, anergia, and
apathy) in a group of both cognitively intact and cognitively
impaired individuals, even after controlling for cognitive
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4.2. Subcortical Gray Matter Lesions and LOD in Alzheimer’s
Disease. The ﬁnding that individuals with LOD and
Alzheimer’s disease had a greater number of striatal hypo-
densities compared to individuals without depression and
Alzheimer’s disease is consistent with several prior imaging
studies of late-life depression in nondemented individu-
als demonstrating a greater prevalence of lesions in the
putamen among individuals with geriatric depression [24]
and reduced caudate nucleus volume among adults with
depression [42]. The striatum represents the subcortical gray
matter components of the fronto-striatal pathway. Thus, the
ﬁnding that individuals with AD and LOD have a greater
amount of striatal hypodensities compared to individuals
with AD and no depression provides some support for the
fronto-striatal hypothesis of depression among individuals
with dementia.
Although Alzheimer’s disease is a “cortical” dementia,
the individuals with LOD had a greater prevalence of
hypodensities in the subcortical gray matter compared to
the individuals with Alzheimer’s disease and no depres-
sion. As subcortical changes are not typically associated
with Alzheimer’s disease, the greater amount of striatal
hypodensities evident in the individuals with Alzheimer’s
disease and LOD may represent a neuropathological process
associated with late-onset depression that is distinct from the
neurodegenerative changes caused by Alzheimer’s disease.
In fact, dementia characterized by the neurodegeneration of
subcortical structures, or subcortical dementia, is often asso-
ciated with depression-like symptoms, which may provide
further support to the idea that the subcortical gray matter
lesions may represent a process speciﬁc to LOD. Therefore,
the individuals in the present study with Alzheimer’s disease
and LOD may have a “double dose” of neuropathology—one
that is primarily cortical (Alzheimer’s disease) and the other
subcortical (LOD).
4.3. Limitations
4.3.1. Technological. This study has several limitations. First
is the use of CT instead of MRI. CT has better speciﬁcity
than MRI for white matter changes of clinical signiﬁcance—
95.5% versus 68.2%, respectively, for frontal white matter
changes, and 95.5% versus 63.3% for whole brain white
matter changes [43]. This was supported by the high
interrater reliability for bilateral WMH ratings; whereas, the
basal ganglia-thalamic hypodensity ratings were relatively
less reliable. However, CT is known for being less sensitive
in detecting subtle microvascular ischemic changes, espe-
cially in individuals with Alzheimer’s disease, the diagnosis
assigned to the majority of this study’s participants. In one
study comparing MRI to CT neuroimaging of individuals
with Alzheimer’s disease, white matter changes in the frontal
lobe were evident in seven out of the 22 participants using
MRI, but only one out of the same 22 participants using CT.
Additionally, sensitivity to mild frontal lobe WMH was only
31.0% for CT imaging versus 75.9% for MRI [43]. Thus, it is
possiblethatthewhitematterchangesfoundbyotherstudies
aretoosubtletobedetectedbyCT.Nonetheless,whitematter
changes in the present study were found to increase with age,
as would be expected, and to be more common in vascular
dementia than in other dementias.
4.3.2. Cross-Sectional Study Design. A major limitation
inherent in the study design is that CT data were available
for only one point in time and on average ﬁve years after
the age of dementia onset. Due to our lack of premorbid CT
data, we can make no causal statements regarding depression
and the presence of white or gray matter hypodensities, nor
can we make any statements about change over time relative
to progression of dementia. At the same time, somewhat
surprisingly, there was not a signiﬁcant relationship between
duration of dementia and amount of white matter hypoden-
sities in either the frontal lobe or subcortical white matter.
For striatal hypodensities, there was no relationship when
the entire sample was examined as a whole. Taken together
with the greater amount of striatal hypodensities in the
LOD/Alzheimer’s disease group compared to nondepressed
Alzheimer’s disease group, this association, although cross-
sectional, lends further support to the idea that there may be
two separate neurodegenerative processes occurring among
the individuals with comorbid Alzheimer’s disease and
LOD.
4.3.3.DepressionAssessment. Anotherlimitationwasthatthe
methods for ascertaining a history of depression were more
sensitive to detecting recent episodes. Indeed, in our sample
only 8.2% had a depressive episode prior to age 60, which
is well below the estimated lifetime prevalence rate of 19.5%
for major depression in Swedish twins [44]. Thus individuals
in the late-onset group may have been misclassiﬁed due
to unreported early episodes of depression, although they
would have been correctly classiﬁed in analyses of late-life
depression. In addition, ﬁndings from a recent study of
the population from which the present study sample was
drawn indicated that depression closer in time to dementia
onset, and not earlier life depression, was associated with
an increased risk of dementia [3]. Therefore, it is also
possible that there was diﬀerential survival in individuals
with early-onset depression, such that they were not as likely
as individuals with LOD to develop dementia, and thus were
underrepresented as a whole in this sample.
Another limitation stems from the fact that there is no
consensus as to what age constitutes early-onset versus late-
onset and late-life depression. A recent meta-analysis [45]o f
WMH in late-life depression noted that there was substantial
variabilityacrossstudiesintheagecutoﬀsusedtodeﬁnelate-
onset depression, with ages ranging from 45 to 65 years of
age. Whereas Alexopoulos et al. [29] proposed that vascular
depression be deﬁned by an age of onset after 65 years,
Krishnan et al. [46] suggested a deﬁnition using an age cutoﬀ
of 50 years. Devanand et al. [47] recommended an age cutoﬀ
of 60 years because diﬀerences in cardiovascular risk factors
between an earlier versus a later age of depression onset are
greatest at this point.
Another reason for the diﬀerences in ﬁndings between
our study and the ﬁndings of some previous studies of
depression in those without dementia could be the nature10 Journal of Aging Research
of our depression measures. Our depression measures were
dichotomous, and there was no way to distinguish between
levels of depression severity. As suggested by previous studies
of late-life depression (e.g., [21, 23]) white matter changes
are related to the severity of late-onset depression, with
diﬀerencesbetweennon-depressedandlate-onsetdepression
groups being evident only when the level of depression is rel-
atively severe. Therefore, as the late-onset depression group
in our study likely represented a wide range of depression
severity (and because there were not enough individuals in
our sample for a separate analysis with depression severe
enough to require hospitalization), diﬀerences between the
non-depressed and LOD groups could have been obscured
due to the number of individuals with milder levels of
depression.
5. Conclusions
In support of the fronto-striatal hypothesis of depression,
the results of the present study indicated that among
individuals with Alzheimer’s disease, there was a signiﬁcant
relationship between late-onset depression and a greater
amount of striatal hypodensities (gray matter hypodensities
in the caudate nucleus and lentiform nucleus) compared
to people with no depression. As subcortical changes
are not typically associated with Alzheimer’s disease, the
greater amount of striatal hypodensities evident in the
individuals with Alzheimer’s disease and LOD may repre-
sent a neuropathological process that is distinct from the
neurodegenerative changes caused by Alzheimer’s disease.
We did not ﬁnd an association between LOD/LLD and
white matter hypodensities in the frontal deep white matter
or subcortical white matter. Other studies in individuals
without dementia ﬁnding such an association have typically
used MRI. Thus, associated white matter changes may have
been too subtle to be detected by CT imaging. However, as
prior studies were among individuals without dementia, it
is equally likely that the neurological damage in the white
matter caused by dementia subsumes the neuropathology
of late-onset depression, such that the two neuropathologies
become indistinct with respect to white matter. Thus, for
older adults with dementia and late-life depression, there
are important public health implications for identifying the
pathophysiologic mechanisms linking these two conditions.
Given that many treatments for depression are mediated by
neurobiological factors, the eﬃcacy of these treatments may
becompromisedinindividualswithneuroanatomicalabnor-
malities. An understanding of the unique brain changes
associated with dementia versus those associated with LOD
may elucidate avenues for treatments with better eﬃcacy in
older adults.
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